跳至主要内容
临床试验/NCT00898170
NCT00898170已完成不适用

Effect of Myoma Removal on Blood Pressure and Erythropoetin Level

Shiraz University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2008年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
28
试验地点
1
主要终点
24 hour holter monitoring of blood pressure

研究概览

简要总结

The effect of myoma removal was studied on 28 patients with hypertension and myoma by holter monitoring and erythropoetin level check.

详细描述

Background:

Myoma is the most common gynecoid tumor and produces many vasoactive substances, which may be a cause for secondary hypertension. Early reports suggested the association of myoma and hypertension. We studied the effect of myoma removal on hypertension and erythropoietin level to evaluate this hypothesis.

Patients & Methods:

In this single centered prospective cohort study, in twenty eight patients who were candidates for myomectomy due to myoma, 24 hour holter monitoring of blood pressure and serum erythropoietin were checked before and 6 weeks after hysterectomy.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
22 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • candidate for myoma removal by hysterectomy
  • hysterectomy is indicated

排除标准

  • patient refusal
  • inoperable patients
  • other secondary cases of hypertension

结局指标

主要结局

24 hour holter monitoring of blood pressure

时间窗: 6 weeks

次要结局

  • erythropoetin level(6 weeks)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验